Bach R, Jung F
Dresdner Institut für Herz- und Kreislaufforschung, Dresden.
Herz. 1998 Feb;23(1):35-41. doi: 10.1007/BF03043010.
Side effects must be expected in 7 to 8% of cases, even when non-ionic radiocontrast agents are used. Contrast agent-induced microcirculatory disturbances constitute one potential cause under discussion. These disturbances may be caused by either the hyperviscosity or the hyperosmolality of the contrast agents. Within the framework of 3 comparative studies, the influence of viscosity and/or osmolality in intraarterial bolus injections on downstream microcirculation was tested in patients with coronary heart disease. Blood flow in the nailfold capillaries was recorded by intravital videomicroscopy and evaluated off-line, before and after randomized injection of 20 ml of each different radiocontrast agent into the Arteria auxillaries ipsilateral. Injection of 20 ml of a radiographic contrast agent into the Arteria auxillaries with a viscosity of 9.9 mPas and an osmolality of 770 mOsmol/kg H2O (Iopromid with 370 mg iodine/ml) results in a significant reduction in mean erythrocyte velocity in the ipsilateral nailfold capillaries from 0.76 +/- 0.27 to 0.39 +/- 0.31 mm/s after 30 s (p = 0.0001), corresponding to a reduction of 51.3%, whereas electrolyte solution shows no influence. With one exception, all patients reacted with a pronounced reduction in perfusion following injection of the radiocontrast agent, 3 patients showed an extreme reaction with flow cessation in the capillaries, in 1 case lasting up to 2 minutes. Following injection of 20 ml of Iodixanol with 270 mg iodine/ml (5.8 mPas, 290 mOsmol/kg H2O) a significant reduction of mean erythrocyte velocity of 60.8% was recorded from 0.44 +/- 0.27 mm/s to 0.17 +/- 0.09 mm/s only 10 s after the injection (p = 0.0001) lasting to the end of the observation period (6 minutes). Following injection of 20 ml of low-viscosity Iopentol with 150 mg iodine/ml and comparable osmolality (1.7 mPas, 340 mOsmol/kg H2O) no change in erythrocyte velocity was recorded (p = 0.151). Following injection of 2 high-viscosity radiocontrast agents of varying osmolality, mean erythrocyte velocity is reduced significantly in the first 30 s, after which period the erythrocyte velocity gradually increases (ANOVA repeated measures, category "time": p < 0.0001). The time curve for the 2 radiocontrast agents do not, however, differ (ANOVA, category "agents x time": p = 0.9890). Perfusion of the nailfold capillaries depends significantly on the viscosity, but not the osmolality, of the radiocontrast agent injected in coronary heart disease patients. From a microcirculatory point of view, it would therefore make sense to use low-viscosity radiocontrast agents in outpatients to exclude the existing risk of an induced myocardial microcirculatory disturbance.
即使使用非离子型放射性造影剂,7%至8%的病例仍可能出现副作用。造影剂引起的微循环紊乱是正在讨论的一个潜在原因。这些紊乱可能由造影剂的高粘度或高渗性引起。在3项比较研究的框架内,对冠心病患者进行了动脉团注时粘度和/或渗透压对下游微循环影响的测试。通过活体视频显微镜记录甲襞毛细血管中的血流,并在随机向同侧腋动脉注射20 ml每种不同的放射性造影剂之前和之后离线评估。向粘度为9.9 mPas、渗透压为770 mOsmol/kg H2O(含370 mg碘/ml的碘普罗胺)的腋动脉注射20 ml造影剂后,同侧甲襞毛细血管中的平均红细胞速度在30秒后从0.76±0.27显著降低至0.39±0.31 mm/s(p = 0.0001),相当于降低了51.3%,而电解质溶液则无影响。除1例例外,所有患者在注射造影剂后灌注均显著降低,3例患者出现极端反应,毛细血管血流停止,1例持续长达2分钟。注射20 ml含270 mg碘/ml的碘克沙醇(5.8 mPas,290 mOsmol/kg H2O)后,仅在注射后10秒平均红细胞速度就显著降低了60.8%,从0.44±0.27 mm/s降至0.17±0.09 mm/s,并持续至观察期结束(6分钟)(p = 0.0001)。注射20 ml含150 mg碘/ml且渗透压相当(1.7 mPas,340 mOsmol/kg H2O)的低粘度碘喷托后,红细胞速度无变化(p = 0.151)。注射2种渗透压不同的高粘度放射性造影剂后,平均红细胞速度在最初30秒显著降低,此后红细胞速度逐渐增加(重复测量方差分析,“时间”类别:p < 0.0001)。然而,这2种放射性造影剂的时间曲线并无差异(方差分析,“造影剂×时间”类别:p = 0.9890)。冠心病患者甲襞毛细血管的灌注显著取决于所注射造影剂的粘度,而非渗透压。因此,从微循环的角度来看,在门诊患者中使用低粘度放射性造影剂以排除诱发心肌微循环紊乱的现有风险是有意义的。